Akila Viswanathan MD MPH
Professor and Chair of Radiation Oncology, Johns Hopkins
Join to View Full Profile
401 North Broadway StreetWeinberg Building, Floor-L2Baltimore, MD 21287
Phone+1 410-955-6980
Fax+1 410-502-1419
Dr. Viswanathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Akila Viswanathan is a radiation oncologist based in Baltimore, MD, specializing in gynecologic radiation oncology. She completed her residency at Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School after earning her medical degree from the University of Pittsburgh School of Medicine. She holds an MSc and MPH in Epidemiology from Harvard School of Public Health, as well as an A.B. from Harvard University. Dr. Viswanathan is the Chair of Radiation Oncology at Johns Hopkins Medicine. Her recent publications include work on cervical cancer brachytherapy and innovations in radiation therapy. She has led several clinical trials focused on gynecologic cancers, including image-guided and intensity-modulated radiation therapies. Her accolades include being named America's Top Doctor, and being recognized as a Most Compassionate Doctor and a Super Doctor.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1998 - 2002
University of Pittsburgh School of MedicineClass of 1997
Harvard School of Public HealthMSc, Epidemiology
Harvard School of Public HealthMPH
Harvard UniversityA.B.
Certifications & Licensure
FL State Medical License 2025 - Present
DC State Medical License 2016 - 2027
MD State Medical License 2016 - 2027
VA State Medical License 2022 - 2026
PA State Medical License 2020 - 2022
MA State Medical License 1998 - 2017
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctor Castle Connolly, 2014-2015
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Most Compassionate Doctor American Registry
- Join now to see all
Clinical Trials
- Magnetic Resonance Imaging Guided Gynecologic Brachytherapy Start of enrollment: 2003 Mar 01
- Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
- Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Start of enrollment: 2009 Nov 06
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and safety of twice-daily accelerated hyperfractionated re-irradiation for thoracic malignancies.Victoria L Doss, Cecilia F P M de Sousa, Elaina Hales, Tinker Trent, Esi Hagan
Radiotherapy and Oncology. 2025-09-10 - Roadmap: medical physics technologies in brachytherapy.William Y Song, Michael Roumeliotis, Junghoon Lee, Aaron Fenster, Jessica Rodgers
Physics in Medicine and Biology. 2025-07-16 - A simulated annealing-based Bayesian network structure optimization framework for late morbidity prediction with a large prospective dataset.Kailyn Stenhouse, Philip McGeachy, Sofia Spampinato, Kari Tanderup, Kathrin Kirchheiner
Medical Physics. 2025-06-01
Press Mentions
On Target with Dr. Akila Viswanathan – ASTRO 2025October 14th, 2025- Radiation Oncology and Its Role in the Treatment of Endometrial CancerOctober 24th, 2024
- CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar CancerMarch 27th, 2023
- Join now to see all
Grant Support
- CaREER: Cancer Research Education Excellence in RadiotherapyJOHNS HOPKINS UNIVERSITY2024–2029
- CaREER: Cancer Research Education Excellence in RadiotherapyJOHNS HOPKINS UNIVERSITY2024–2029
- Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical CancerNANOCAN THERAPEUTICS CORPORATION2025–2026
- Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical CancerNANOCAN THERAPEUTICS CORPORATION2025–2026
- Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placementJOHNS HOPKINS UNIVERSITY2020–2025
- Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placementJOHNS HOPKINS UNIVERSITY2020–2025
- Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placementNCI2020–Present
- MR-Guided Gynecologic BrachytherapyNIH2013–2018
- Inflammation and Endometrial CancerNCI2006–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
